BacMuno's Incubator/Accelerator Round

BacMuno raised a round of funding on August 14, 2017. Investors include Hong Kong X.

BacMuno is a pharmaceutical biotechnology company developing bacteria-based cancer immuno-therapies for humans and animals through the use of unique Salmonella based technology.…

Articles about BacMuno's Incubator/Accelerator Round: